Modeling Parkinson's Disease With the Alpha-Synuclein Protein.

Gómez-Benito M, Granado N, García-Sanz P, Michel A, Dumoulin M, Moratalla R. · 2020

Read Modeling Parkinson's Disease With the Alpha-Synuclein Protein. by Gómez-Benito M, Granado N, García-Sanz P, Michel A, Dumoulin M, Moratalla R. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7191035.txt.

Description

Gómez-Benito and co-authors review animal models of Parkinson's disease built around alpha-synuclein. Their article appeared in Frontiers in Pharmacology. This protein clumps into Lewy bodies in the Parkinson's brain. Dopamine-producing cells in the substantia nigra die off. Mutations in the protein's gene cause inherited forms of the disease.

Good models must copy both the cell loss and the spreading clumps. The review covers models that add the protein by gene or injection. It tracks how clumps appear and neurons decline over time. Some models show gradual loss of dopamine markers after injection. Others miss parts of the human picture. The authors judge each model's strengths and gaps. Such models remain central to testing future treatments.

Catalog record

CREATORGómez-Benito M, Granado N, García-Sanz P, Michel A, Dumoulin M, Moratalla R.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE88 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7191035

Browse the full library · About the Tower of Babel